129 related articles for article (PubMed ID: 20034526)
1. Intermittent MTII application evokes repeated anorexia and robust fat and weight loss.
Zhang Y; Collazo R; Gao Y; Li G; Scarpace PJ
Peptides; 2010 Apr; 31(4):639-43. PubMed ID: 20034526
[TBL] [Abstract][Full Text] [Related]
2. Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression.
Li G; Zhang Y; Wilsey JT; Scarpace PJ
J Endocrinol; 2004 Jul; 182(1):123-32. PubMed ID: 15225137
[TBL] [Abstract][Full Text] [Related]
3. Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss.
Li G; Zhang Y; Rodrigues E; Zheng D; Matheny M; Cheng KY; Scarpace PJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E252-8. PubMed ID: 17389713
[TBL] [Abstract][Full Text] [Related]
4. Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction.
Côté I; Green SM; Morgan D; Carter CS; Tümer N; Scarpace PJ
Can J Physiol Pharmacol; 2018 Mar; 96(3):308-312. PubMed ID: 29131966
[TBL] [Abstract][Full Text] [Related]
5. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice.
Tolle V; Low MJ
Diabetes; 2008 Jan; 57(1):86-94. PubMed ID: 17909095
[TBL] [Abstract][Full Text] [Related]
6. MTII administered peripherally reduces fat without invoking apoptosis in rats.
Choi YH; Li C; Hartzell DL; Lin J; Della-Fera MA; Baile CA
Physiol Behav; 2003 Jul; 79(2):331-7. PubMed ID: 12834806
[TBL] [Abstract][Full Text] [Related]
7. Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat.
Glavas MM; Joachim SE; Draper SJ; Smith MS; Grove KL
Endocrinology; 2007 Jul; 148(7):3279-87. PubMed ID: 17412803
[TBL] [Abstract][Full Text] [Related]
8. Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins.
Li YZ; Davidowa H
J Neurosci Res; 2004 Aug; 77(4):596-602. PubMed ID: 15264229
[TBL] [Abstract][Full Text] [Related]
9. Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.
Côté I; Sakarya Y; Kirichenko N; Morgan D; Carter CS; Tümer N; Scarpace PJ
Can J Physiol Pharmacol; 2017 Feb; 95(2):206-214. PubMed ID: 28051332
[TBL] [Abstract][Full Text] [Related]
10. The melanocortin agonist melanotan II increases insulin sensitivity in OLETF rats.
Banno R; Arima H; Sato I; Hayashi M; Goto M; Sugimura Y; Murase T; Oiso Y
Peptides; 2004 Aug; 25(8):1279-86. PubMed ID: 15350695
[TBL] [Abstract][Full Text] [Related]
11. Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance.
Zhang Y; Matheny M; Tümer N; Scarpace PJ
Neurobiol Aging; 2004; 25(10):1349-60. PubMed ID: 15465633
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis.
Choi YH; Li C; Page K; Westby A; Della-Fera MA; Lin J; Hartzell DL; Baile CA
Physiol Behav; 2003 Sep; 79(4-5):795-801. PubMed ID: 12954425
[TBL] [Abstract][Full Text] [Related]
13. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats.
Cettour-Rose P; Rohner-Jeanrenaud F
Endocrinology; 2002 Jun; 143(6):2277-83. PubMed ID: 12021192
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation.
Brito MN; Brito NA; Baro DJ; Song CK; Bartness TJ
Endocrinology; 2007 Nov; 148(11):5339-47. PubMed ID: 17702843
[TBL] [Abstract][Full Text] [Related]
15. Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation.
do Carmo JM; Bassi M; da Silva AA; Hall JE
Hypertension; 2011 Mar; 57(3):428-34. PubMed ID: 21263126
[TBL] [Abstract][Full Text] [Related]
16. Anatomical dissociation of melanocortin receptor agonist effects on taste- and gut-sensitive feeding processes.
Baird JP; Palacios M; LaRiviere M; Grigg LA; Lim C; Matute E; Lord J
Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R1044-56. PubMed ID: 21734020
[TBL] [Abstract][Full Text] [Related]
17. Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat.
Williams DL; Bowers RR; Bartness TJ; Kaplan JM; Grill HJ
Endocrinology; 2003 Nov; 144(11):4692-7. PubMed ID: 12960080
[TBL] [Abstract][Full Text] [Related]
18. Assessment of voluntary ethanol consumption and the effects of a melanocortin (MC) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor.
Navarro M; Lerma-Cabrera JM; Carvajal F; Lowery EG; Cubero I; Thiele TE
Alcohol Clin Exp Res; 2011 Jun; 35(6):1058-66. PubMed ID: 21332528
[TBL] [Abstract][Full Text] [Related]
19. Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness.
Li G; Zhang Y; Cheng KY; Scarpace PJ
Diabetologia; 2007 Jul; 50(7):1490-9. PubMed ID: 17505816
[TBL] [Abstract][Full Text] [Related]
20. Feeding response to melanocortin agonist predicts preference for and obesity from a high-fat diet.
Chandler PC; Viana JB; Oswald KD; Wauford PK; Boggiano MM
Physiol Behav; 2005 Jun; 85(2):221-30. PubMed ID: 15893778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
